Tidal Investments LLC Sells 45,113 Shares of Merit Medical Systems, Inc. $MMSI

Key Points

• Tidal Investments reduced its Merit Medical Systems stake by 22% in the second quarter, selling 45,113 shares and retaining 160,234 shares valued at approximately $11.1 million. Institutional investors collectively own 99.66% of the company.
• Merit Medical reported quarterly EPS of $1.19, exceeding analyst estimates of $0.96, while revenue rose 9.5% year over year to $418.84 million. The company provided fiscal 2026 EPS guidance of $4.25–$4.35.
• Analysts maintain a generally positive outlook, with the stock carrying a consensus “Moderate Buy” rating and a $100 average price target versus its recent price of $86.36.

Tidal Investments LLC trimmed its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 22.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 160,234 shares of the medical instruments supplier's stock after selling 45,113 shares during the period. Tidal Investments LLC owned about 0.27% of Merit Medical Systems worth $11,111,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. Van Hulzen Asset Management LLC lifted its holdings in shares of Merit Medical Systems by 25.0% during the 2nd quarter. Van Hulzen Asset Management LLC now owns 28,877 shares of the medical instruments supplier's stock valued at $2,002,000 after purchasing an additional 5,778 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in Merit Medical Systems during the 2nd quarter worth approximately $199,000. Squarepoint Ops LLC raised its holdings in Merit Medical Systems by 17.2% during the 2nd quarter. Squarepoint Ops LLC now owns 27,458 shares of the medical instruments supplier's stock worth $1,904,000 after buying an additional 4,020 shares during the period. Allworth Financial LP lifted its stake in Merit Medical Systems by 1,661.5% in the second quarter. Allworth Financial LP now owns 1,920 shares of the medical instruments supplier's stock valued at $133,000 after buying an additional 1,811 shares in the last quarter. Finally, Arizona State Retirement System lifted its stake in Merit Medical Systems by 1.1% in the second quarter. Arizona State Retirement System now owns 16,459 shares of the medical instruments supplier's stock valued at $1,141,000 after buying an additional 174 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Stock Down 0.1%

Shares of MMSI stock opened at $86.36 on Friday. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $94.75. The stock has a market cap of $5.16 billion, a price-to-earnings ratio of 35.69, a PEG ratio of 2.16 and a beta of 0.49. The firm's 50-day moving average is $83.57 and its 200-day moving average is $73.41. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.23. The business had revenue of $418.84 million during the quarter, compared to analysts' expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.Merit Medical Systems's quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company posted $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Sell-side analysts predict that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on MMSI shares. Zacks Research raised shares of Merit Medical Systems from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 25th. Wells Fargo & Company boosted their price objective on shares of Merit Medical Systems from $74.00 to $83.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Raymond James Financial reaffirmed an "outperform" rating and issued a $100.00 target price on shares of Merit Medical Systems in a research note on Friday, July 31st. BTIG Research reiterated a "buy" rating and set a $105.00 target price on shares of Merit Medical Systems in a report on Tuesday, August 11th. Finally, Robert W. Baird set a $98.00 price target on Merit Medical Systems in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Merit Medical Systems has an average rating of "Moderate Buy" and a consensus target price of $100.00.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its portfolio is designed primarily for use by physicians in hospitals, outpatient facilities and other healthcare settings.

The company's products support a range of specialties, including cardiovascular intervention, peripheral intervention, oncology, spine and pain management, general surgery, and critical care.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.